It seems to me we have been anticipating the FDA's assessment of CSL112 for the best part of 2 decades...I'd like to think CSL would have pulled the plug on this potential blockbuster long before now if they were not pretty convinced that CSL112 will quickly become the standard-of-care therapy for the misfortunate folks who suffer a heart attack.
It seems to me we have been anticipating the FDA's assessment of...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$307.69 |
Change
-0.240(0.08%) |
Mkt cap ! $148.6B | |||
| Open | High | Low | Value | Volume |
| $309.31 | $309.89 | $307.31 | $86.23M | 294.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 22 | $307.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $307.72 | 22 | 3 |
View Market Depth
| Last trade - 14.01pm 30/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |